1. Olah KS, Gee H, Blunt S, Dunn JA, Chan KK.
Retrospective analysis of 318 cases of uterine sarcoma.
Eur J Cancer 1991, 27: 1095-1099.
2. Levenbeck CF, Tortolero LG, Pandey DK, Malpica A,
Baker VV, Whittaker L, Johnson E, Follen Mitchell M.
Uterine Sarcoma In Follen Mitchell M, Schottenfeld D,
Kitlong W (eds): Obstetrics and Gynecology Clinics of
North America, Gynecologic Cancer Prevention, 1996,
23: 457- 473.
3. Page HS, Asire AJ. Cancer rates and risks. NIH
Publication No: 85-691, Washington DC, US Department
of Health and human Services, 1985.
4. Schwartz Z, Dgani R, Lancet M, Kesser I. Uterine
sarcoma in Israel: a study of 104 cases. Gynecol Oncol
1985, 20: 354-363.
5. Harlow BL, Weiss NS, Lofton S. The epidemiology of
Sarcomas of the uterus. J Natl Cancer Inst 1986, 76: 399-
402.
6. Dihn TV, Slavin RE, Bhangavan BJ, Hannigan Ev,
Tiamson EM, Yandell RB. Mixed Müllerian Tumors of
the uterus: a clinicopathological study. Obstet Gynecol
1989, 74: 388-392.
7. Marchese MJ, Liskow AS, Crum CP. Uterine sarcoma. A
clinicopathologic study 1965-1981. Gynecol Oncol 1984,
18: 299-304.
8. Cristopherson WM, Williamson EO, Gray LA.
Leimyosarcoma of the uterus. Cancer 1972, 29: 1512-
1516.
9. Harlow BL, Weiss NS, Lofton S. The epidemiology of
the sarcomas of the uterus. JNCI 1986, 76: 399.
10. Fenton AN, Burke L. Sarcoma of the uterus: A record of
26 cases. Am J Obstet Gynecol 1952, 63: 158.
11. Rose PG. Uterine sarcoma. In Piver MS(ed): The
Handbook of Gynecologic Oncology. 2nd edition, Little
Brown Co., Boston, 1996, 159.
12. Atasü T, Uludağ S, Girişken G. Endometrial Stromal
Sarcoma. Cerrahpaşa Tõp Bülteni 1983, 15: 65-70.
13. Echt G, Jepson J, Steel J. Treatment of uterine sarcoma.
Cancer 1990, 66: 35-39.
14. Harlow BL, Weiss NS, Lofton S. The epidemiology of
sarcomas of the uterus. J Natl Cancer Inst 1986, 76: 399-
402.
15. Laxman R, Currie JL, Kurman RJ et al. Cytogenetic
profile of uterine sarcomas. Cancer 1993, 71: 1283.
16. Taina E, Maenpaa J, Erkkola R. Endometrial stromal
sarcoma.A report of 9 cases. Gynecol Oncol 1989, 32:
156-162.
17. Crabtree T, Kempson RL, Hendrickson MR. Endometrial
stromal sarcoma: a clinicopathological study of 56 cases.
Lab Invest 1985, 52: 198.
18. Norris HJ, Taylor HB. Mesenchymal tumors of the
uterus.I A clinicopathological study of 53 endometrial
stromal tumors. Cancer 1966, 19: 755-766.
19. Malmstrom H, Schmidt H, Persson PG et al.
Flowcytometric analysis of uterine sarcoma: ploidy ans S
phase rate as prognostic indicators. Gynecol Oncol 1992,
44: 172.
20. Kahanpaa KV, Wahlstorm TA, Grohn P. Sarcomas of the
uterus a clinopathological study of 119 patients. Obstet
gynecol 1986, 67:417-424.
21. Piver MS, Rutledge FN, Copeland L et al. Uterine
endolymphatic stromal myosis: a collaborative study.
Obstet Gynecol 1984, 64:173.
22. Kuryak A, Kupesic S, Shalan H et al. Uterine sarcoma: a
report of 10 cases studied by transvaginal color and
pulsed doppler sonography. Gynecol Oncol 1995, 59:342.
23. Pastner B, Mann WJ. Use of serum Ca.125 in monitoring
patients with uterine sarcoma: a preliminary report.
Cancer 1988, 62: 1355.
24. Mansi JL, Ramachandura S, Wiltshaw E. Endometrial
stromal sarcomas. Gynecol Oncol 1984,36: 113-118.
25. Salazar OM, Bonfiglio TA, Patten S. Uterine sarcomas:
Natural history, treatment and prognosis. Cancer 1978,
42: 1152-1160.
26. Goff BA, Rice LW, Fleischhacker D. Uterine
leiomyosarcoma and endometrial stromal sarcoma:
Lymph node metastases and sites of recurrence. Gynecol
Oncol 1993, 50: 105-109.
27. Edmonson JH, Ryan LM, Blum RH. Randomized
comparison of doxorubicin alone versus ifofosfamide
plus doxorubicin or mitomycin, doxorubicin and cisplatin
against soft tissue sarcomas. J Clin Oncol 1993, 11:
1269-1275.
28. Montag TW, Manart FD. Endolymphatic stromal myosis:
Surgical and hormonal theraphy for extensive venous
recurrence. Gynecol Oncol 1989, 33: 255-260.
